Cogent Biosciences, Inc. (COGT) Revenue 2018–2021
Cogent Biosciences, Inc. (COGT) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$7.9MFY2021 · since FY2018: $8.4M → $7.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $7.9M | -65.0% |
| FY2020 | $22.5M | +131.1% |
| FY2019 | $9.7M | +16.4% |
| FY2018 | $8.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More COGT financial trends
COGT Net incomeCOGT Net marginCOGT Gross profitCOGT Gross marginCOGT Operating incomeCOGT Operating marginCOGT Operating cash flowCOGT Free cash flowCOGT Capital expendituresCOGT Return on equityCOGT Stock buybacksCOGT Dividends paidCOGT Total assetsCOGT Total liabilitiesCOGT Shareholders’ equityCOGT overview →